Surgical Oncology

por Sacks, N.P.M.
Publicado 1991

Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen.

por Allan, S. M., Dean, C., Fernando, I., Eccles, S., Styles, J., McCready, V. R., Baum, M., Sacks, N.
Publicado 1993

Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.

por Stacker, S. A., Sacks, N. P., Golder, J., Tjandra, J. J., Thompson, C. H., Smithyman, A., McKenzie, I. F.
Publicado 1988

S48. Biomarker development for ipilimumab and prostate GVAX treatment

por de Gruijl, T, Santegoets, S, Stam, A, Lougheed, S, Jooss, K, Sacks, N, Harding, T, Hege, K, Gerritsen, W, van den Eertwegh, A
Publicado 2014

Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.

por Sacks, N. P., Stacker, S. A., Thompson, C. H., Collins, J. P., Russell, I. S., Sullivan, J. A., McKenzie, I. F.
Publicado 1987

The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study.

por Tjandra, J. J., Sacks, N. P., Thompson, C. H., Leyden, M. J., Stacker, S. A., Lichtenstein, M., Russell, I. S., Collins, J. P., Andrews, J. T., Pietersz, G. A.
Publicado 1989

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer

por Archer, C D, Parton, M, Smith, I E, Ellis, P A, Salter, J, Ashley, S, Gui, G, Sacks, N, Ebbs, S R, Allum, W, Nasiri, N, Dowsett, M
Publicado 2003